BACKGROUND: The aim of this study was to evaluate the short- and long-term outcomes after @entity348 ( @entity348 ) with D2 lymphadenectomy. METHODS: @entity1 undergoing @entity348 with D2 lymphadenectomy for @entity356 between December 2008 and December 2011 were enrolled. Univariate and multivariate analyses were performed to evaluate the risk factors for the short- and long-term outcomes. RESULTS: A total of 229 @entity1 were analyzed, and 22.3  % developed complications within 30  days of surgery. No @entity1 died within 30  days, while 2.6  % died within 90  days of the operation. In the multivariate analysis, age >= 65  years and cardiopulmonary comorbidities were associated with morbidity, whereas @entity9427 and @entity5 -node-metastasis (TNM) stage III were associated with the disease-free survival (DFS) and overall survival (OS). The number of preoperative risk factors stratified the morbidity from 10.3  % in those without any risk factors to 40.5  % in @entity1 with both risk factors. Similarly, 5-year survival rates decreased from 68.9  % (DFS) and 71.1  % (OS) in those without risk factors to 20.2  % (DFS) and 22.9  % (OS) in @entity1 with both risk factors. CONCLUSION: @entity348 with D2 lymphadenectomy has acceptable short- and long-term outcomes. @entity1 risk stratification may allow for more rational selection of @entity1 and therapeutic strategies for gastric resection.

Feasibility of Total Gastrectomy with D2 Lymphadenectomy for XXXX and Predictive Factors for Its Short- and Long-Term Outcomes.

@entity1 :: ('9606', 'Species') :: ['Patients', 'patients', 'patient', 'Patient'] @entity5 :: ('MESH:D009369', 'Disease') :: ['tumor'] @entity348 :: ('MESH:C535338', 'Disease') :: ['total gastrectomy', 'TG'] @entity9427 :: ('MESH:D007019', 'Disease') :: ['hypoproteinemia'] @entity356 :: ('MESH:D013274', 'Disease') :: ['gastric cancer']
@entity356 :: (MESH:D013274,Disease) :: ['Gastric Cancer']
